BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22548705)

  • 1. Temporally distinct roles for tumor suppressor pathways in cell cycle arrest and cellular senescence in Cyclin D1-driven tumor.
    Zalzali H; Harajly M; Abdul-Latif L; El-Chaar N; Dbaibo G; Skapek SX; Saab R
    Mol Cancer; 2012 May; 11():28. PubMed ID: 22548705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
    Saab R; Rodriguez-Galindo C; Matmati K; Rehg JE; Baumer SH; Khoury JD; Billups C; Neale G; Helton KJ; Skapek SX
    Cancer Res; 2009 Jan; 69(2):440-8. PubMed ID: 19147556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention.
    Zalzali H; Nasr B; Harajly M; Basma H; Ghamloush F; Ghayad S; Ghanem N; Evan GI; Saab R
    Mol Cancer Res; 2015 Jan; 13(1):29-40. PubMed ID: 25149358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2.
    Lan Z; Sever-Chroneos Z; Strobeck MW; Park CH; Baskaran R; Edelmann W; Leone G; Knudsen ES
    J Biol Chem; 2002 Mar; 277(10):8372-81. PubMed ID: 11726663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation of p21 and Chk1 controls the cyclin D1-RB pathway to mediate senescence onset after G2 arrest.
    Lossaint G; Horvat A; Gire V; Bačević K; Mrouj K; Charrier-Savournin F; Georget V; Fisher D; Dulić V
    J Cell Sci; 2022 Apr; 135(8):. PubMed ID: 35343565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
    Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
    Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence.
    Wang XD; Lapi E; Sullivan A; Ratnayaka I; Goldin R; Hay R; Lu X
    Cell Death Differ; 2011 Feb; 18(2):304-14. PubMed ID: 20798689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
    Del Toro N; Fernandez-Ruiz A; Mignacca L; Kalegari P; Rowell MC; Igelmann S; Saint-Germain E; Benfdil M; Lopes-Paciencia S; Brakier-Gingras L; Bourdeau V; Ferbeyre G; Lessard F
    Cell Cycle; 2019; 18(6-7):759-770. PubMed ID: 30874462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for p107 and p130 in Rb-independent cellular senescence.
    Lehmann BD; Brooks AM; Paine MS; Chappell WH; McCubrey JA; Terrian DM
    Cell Cycle; 2008 May; 7(9):1262-8. PubMed ID: 18418057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH; Drullinger LF; Soulard A; Dulić V
    Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer.
    Zarneshan SN; Fakhri S; Bachtel G; Bishayee A
    Adv Protein Chem Struct Biol; 2023; 135():1-19. PubMed ID: 37061329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
    Kan CE; Patton JT; Stark GR; Jackson MW
    Cancer Res; 2007 Oct; 67(20):9862-8. PubMed ID: 17942917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
    Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
    Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21(WAF1) expression.
    Wyllie F; Haughton M; Bartek J; Rowson J; Wynford-Thomas D
    Exp Cell Res; 2003 May; 285(2):236-42. PubMed ID: 12706118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
    Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
    Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.